Phase 3 Membranous Nephropathy Clinical Trials
8 recruitingPhase 3
What is a Phase 3 trial?
Phase 3 trials compare the new treatment against the current standard of care in large groups, often hundreds to thousands of participants. Successful Phase 3 results are typically required for regulatory approval.
Showing 1–8 of 8 trials
Recruiting
Phase 2Phase 3
Evaluation of Efficacy, Safety, and Tolerability of Povetacicept in Participants With Primary Membranous Nephropathy (pMN)
Primary Membranous Nephropathy
Vertex Pharmaceuticals Incorporated176 enrolled86 locationsNCT07204275
Recruiting
Phase 3
A Study to Learn More About the Effects and Safety of Felzartamab Infusions in Adults With Primary Membranous Nephropathy (PMN)
Primary Membranous Nephropathy
Biogen180 enrolled91 locationsNCT06962800
Recruiting
Phase 3
OBINOTUZUMAB Versus Cyclophosphamide + Glucocorticoids in Primary Membranous Nephropathy(Blossom Study)
Primary Membranous Nephropathy
Huashan Hospital144 enrolled1 locationNCT06781944
Recruiting
Phase 2Phase 3
Obinutuzumab Induced Decreases of PLA2R Antibodies in Membranous Nephropathy: a Pilot Study
Membranous Nephropathy - PLA2R Induced
Radboud University Medical Center20 enrolled1 locationNCT07163611
Recruiting
Phase 3
Different Immunosuppressive Treatment in iMN
Idiopathic Membranous Nephropathy
Peking Union Medical College Hospital200 enrolled1 locationNCT04745728
Recruiting
Phase 3
Personalized Rituximab Treatment Based on Artificial Intelligence in Membranous Nephropathy (iRITUX)
Membranous Nephropathy
Centre Hospitalier Universitaire de Nice120 enrolled13 locationsNCT06341205
Recruiting
Phase 2Phase 3
A Clinical Study of B007 in the Treatment of Primary Membranous Nephropathy.
Primary Membranous Nephropathy
Shanghai Jiaolian Drug Research and Development Co., Ltd216 enrolled21 locationsNCT06470191
Recruiting
Phase 3
A Study of SNP-ACTH (1-39) Gel in Patients With Primary Membranous Nephropathy
Primary Membranous Nephropathy
Cerium Pharmaceuticals, Inc.148 enrolled31 locationsNCT05696613